CNMD Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide...

Stats
Šios dienos apimtis	546 382
Vidutinė apimtis	557 580
Rinkos kapitalizacija	2.16B
EPS	$1.060 ( 2024-04-24 )
Kita pelno data	( $0.920 ) 2024-07-24
Last Dividend	$0.200 ( 2023-12-15 )
Next Dividend	$0 ( N/A )
P/E	26.87
ATR14	$0.0970 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Beyer Pat	Buy	3 000	Common Stock
2024-04-24	Beyer Pat	Buy	20 060	Options To Purchase Common Stock
2024-03-28	Garner Todd W	Buy	227	Common Stock
2024-03-28	Cohen Heather L	Buy	227	Common Stock
2024-03-08	Cohen Heather L	Buy	25 000	Common Stock

INSIDER POWER
43.13
Last 96 transactions
Buy: 441 997 \| Sell: 209 124

Tūris Koreliacija

Ilgas: 0.53 (weak)

Trumpas: -0.33 (neutral)

Signal:(47.277) Neutral

Conmed Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AGI	0.902
CCEP	0.902
COO	0.9
DRD	0.9
DECK	0.887
WPM	0.886
PKX	0.881
EUDG	0.88
NVO	0.877
NGG	0.873

10 Labiausiai neigiamai susiję koreliacijos
ENIA	-0.843
DBMF	-0.841
RKLY	-0.836
LXU	-0.832
KMLM	-0.828
NIC	-0.826
GDXD	-0.821
NXQ	-0.817
DGZ	-0.817
DUST	-0.816

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Conmed Corp Koreliacija - Valiuta/Žaliavos

-0.19
( neutral )

0.13
( neutral )

0.00
( neutral )

-0.35
( neutral )

0.57
( weak )

0.13
( neutral )

Conmed Corp Finansinės ataskaitos

Annual	2023
Pajamos:	$1.24B
Bruto pelnas:	$643.07M (51.82 %)
EPS:	$2.10

FY	2023
Pajamos:	$1.24B
Bruto pelnas:	$643.07M (51.82 %)
EPS:	$2.10

FY	2022
Pajamos:	$1.05B
Bruto pelnas:	$571.25M (54.64 %)
EPS:	$-2.68

FY	2021
Pajamos:	$1.01B
Bruto pelnas:	$568.04M (56.21 %)
EPS:	$2.14

Financial Reports:

No articles found.

Conmed Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Conmed Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.56 - Increase likely (51.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2012-03-13
Last Dividend	$0.200	2023-12-15
Next Dividend	$0	N/A
Payout Date	2024-01-05
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$9.25	--
Avg. Dividend % Per Year	0.49%	--
Score	4.91	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.56
Div. Directional Score	9.10	--

Next Divdend (Est)
(2024-07-01)

$0.203 Estimate 40.00 %

Dividend Stability

0.80 Very Good

Dividend Score

4.91

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.600	2.31%
2013	$0.650	2.32%
2014	$0.800	1.87%
2015	$0.800	1.78%
2016	$0.800	1.88%
2017	$0.800	1.81%
2018	$0.800	1.58%
2019	$0.800	1.26%
2020	$0.800	0.72%
2021	$0.800	0.72%
2022	$0.800	0.55%
2023	$0.800	0.89%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0653	1.500	8.69	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0357	1.200	8.81	10.00	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0.298	-1.000	7.02	-7.02	[0 - 1]
currentRatioTTM	2.18	0.800	4.09	3.27	[1 - 3]
quickRatioTTM	0.945	0.800	9.15	7.32	[0.8 - 2.5]
cashRatioTTM	0.116	1.500	-0.466	-0.699	[0.2 - 2]
debtRatioTTM	0.429	-1.500	2.85	-4.27	[0 - 0.6]
interestCoverageTTM	3.66	1.000	9.76	9.76	[3 - 30]
operatingCashFlowPerShareTTM	5.14	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.60	2.00	7.70	10.00	[0 - 20]
debtEquityRatioTTM	1.159	-1.500	5.36	-8.04	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.113	1.000	9.73	9.73	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.160	1.000	-0.223	-0.223	[0.2 - 2]
assetTurnoverTTM	0.546	0.800	9.69	7.75	[0.5 - 2]
Total Score				10.65

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.54	1.000	7.52	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.60	2.00	8.47	10.00	[0 - 30]
dividendYielPercentageTTM	1.171	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.14	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	0.298	1.500	7.02	-7.02	[0 - 1]
pegRatioTTM	1.133	1.500	5.78	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.126	1.000	9.36	0	[0.1 - 0.5]
Total Score				7.56

Conmed Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.